Yali An

3.4k citations

33 papers · 1.9k · 2 hit papers · h-index 11

Impact in

Endocrinology, Diabetes and Metabolism top 1%
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Education
- Diabetes Management and Research
- Diabetes Treatment and Management
Pharmacy top 1%
- Obesity and Health Practices

Papers in

Endocrinology, Diabetes and Metabolism 25
- Diabetes, Cardiovascular Risks, and Lipoproteins 20
- Diabetes Treatment and Management 10
- Diabetes Management and Education 4
- Diabetes Management and Research 3
- Diet, Metabolism, and Disease 2
Molecular Biology 19
- Metabolism, Diabetes, and Cancer 18

Co-authors: Qiuhong Gong (30 shared papers)Jinping Wang (22 shared papers)Guangwei Li (25 shared papers)Yinghua Hu (10 shared papers)Ying Shuai (11 shared papers)Peter H. Bennett (7 shared papers)Edward W. Gregg (6 shared papers)Wenying Yang (6 shared papers)
Journals: Diabetes Care (4 papers)Diabetes Research and Clinical Practice (4 papers)Diabetes Obesity and Metabolism (3 papers)Diabetes (2 papers)Journal of Diabetes (2 papers)
Partner nations: China United States Switzerland

In The Last Decade

Yali An

30 papers receiving 1.8k citations

Hit Papers

align trajectories log scale

Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study 2014 · 444 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2014 The Lancet Diabetes & Endocrinology
2008 The Lancet

Peers

Countries citing papers authored by Yali An

Since Specialization

Citations

This map shows the geographic impact of Yali An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yali An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yali An more than expected).

Fields of papers citing papers by Yali An

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yali An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yali An. The network helps show where Yali An may publish in the future.

Co-authors

The 25 scholars most cited alongside Yali An, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yali An Line = papers co-authored together Yali An links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study The Lancet ·Guangwei Li, Ping Zhang, Jinping Wang, Edward W. Gregg, Wenying Yang, Qiuhong Gong, Hui Li, Hongliang Li, Jiang Yayun, Yali An, Ying Shuai, Bo Zhang, Jingling Zhang, Theodore J. Thompson, Robert B. Gerzoff, Gojka Roglić, Yinghua Hu, Peter H. Bennett Hit paper breakdown →	2008	1154
2	Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study The Lancet Diabetes & Endocrinology ·Guangwei Li, Ping Zhang, Jinping Wang, Yali An, Qiuhong Gong, Edward W. Gregg, Wenying Yang, Bo Zhang, Ying Shuai, Jing Hong, Michael M. Engelgau, Hui Li, Gojka Roglić, Yinghua Hu, Peter H. Bennett Hit paper breakdown →	2014	444
3	Cardiovascular and All-Cause Mortality Over a 23-Year Period Among Chinese With Newly Diagnosed Diabetes in the Da Qing IGT and Diabetes Study Diabetes Care ·Yali An, Ping Zhang, Jinping Wang, Qiuhong Gong, Edward W. Gregg, Wenying Yang, Hui Li, Bo Zhang, Ying Shuai, Yanyan Chen, Michael M. Engelgau, Yiling J. Cheng, Yinghua Hu, Peter H. Bennett, Guangwei Li	2015	72
4	Associations of progression to diabetes and regression to normal glucose tolerance with development of cardiovascular and microvascular disease among people with impaired glucose tolerance: a secondary analysis of the 30 year Da Qing Diabetes Prevention Outcome Study Diabetologia ·Yanyan Chen, Zhang Ping, Jinping Wang, Qiuhong Gong, Yali An, Xin Qian, Bo Zhang, Hui Li, Edward W. Gregg, Peter H. Bennett, Guangwei Li	2021	31
5	Changes in Mortality in People With IGT Before and After the Onset of Diabetes During the 23-Year Follow-up of the Da Qing Diabetes Prevention Study Diabetes Care ·Qiuhong Gong, Ping Zhang, Jinping Wang, Yali An, Edward W. Gregg, Hui Li, Bo Zhang, Ying Shuai, Wenying Yang, Yanyan Chen, Shuqian Liu, Michael M. Engelgau, Yinghua Hu, Peter H. Bennett, Guangwei Li	2016	29
6	Higher blood pressure predicts diabetes and enhances long‐term risk of cardiovascular disease events in individuals with impaired glucose tolerance: Twenty‐three‐year follow‐up of the Daqing diabetes prevention study Journal of Diabetes ·Xiaojue Li, Jinping Wang, Xiaoxia Shen, Yali An, Qiuhong Gong, Hui Li, Bo Zhang, Ying Shuai, Yanyan Chen, Yinghua Hu, Guangwei Li	2018	18
7	Circulating Palmitoyl Sphingomyelin Is Associated With Cardiovascular Disease in Individuals With Type 2 Diabetes: Findings From the China Da Qing Diabetes Study Diabetes Care ·Yanyan Chen, Hong‐Mei Jia, Xin Qian, Jinping Wang, Meng Yu, Qiuhong Gong, Yali An, Hui Li, Sidong Li, Na Shi, Zhong‐Mei Zou, Guangwei Li	2022	16
8	Cancer and its predictors in Chinese adults with newly diagnosed diabetes and impaired glucose tolerance (IGT): a 30-year follow-up of the Da Qing IGT and Diabetes Study British Journal of Cancer ·Siyao He, Jinping Wang, Xiaoxia Shen, Xin Qian, Yali An, Qiuhong Gong, Bo Zhang, Bo Chen, Lihong Zhang, Xiaoping Chen, Yanyan Chen, Guangwei Li	2022	12
9	Roxarsone transformation and its impacts on soil enzyme activity in paddy soils: A new insight into water flooding effects Environmental Research ·Yanping Zhao, Jinli Cui, Liping Fang, Yali An, Shuchai Gan, Pengran Guo, Jianghan Chen	2021	11
10	Long-term influence of type 2 diabetes and metabolic syndrome on all-cause and cardiovascular death, and microvascular and macrovascular complications in Chinese adults — A 30-year follow-up of the Da Qing diabetes study Diabetes Research and Clinical Practice ·Siyao He, Jinping Wang, Xiaoxing Zhang, Xin Qian, Shuang Yan, Wenjuan Wang, Bo Zhang, Xiaoping Chen, Yali An, Qiuhong Gong, Lihong Zhang, Xiaolin Zhu, Hui Li, Yanyan Chen, Guangwei Li	2022	10
11	Prediction of 10-year mortality using hs-CRP in Chinese people with hyperglycemia: Findings from the Da Qing diabetes prevention outcomes study Diabetes Research and Clinical Practice ·Xin Qian, Siyao He, Jinping Wang, Qiuhong Gong, Yali An, Hui Li, Yanyan Chen, Guangwei Li	2021	10
12	Premature death and risk of cardiovascular disease in young-onset diabetes: a 23-year follow-up of the Da Qing Diabetes Study Endocrine ·Yuanchi Hui, Jinping Wang, Yali An, Qiuhong Gong, Hui Li, Bo Zhang, Ying Shuai, Yanyan Chen, Yinghua Hu, Guangwei Li	2019	8
13	Hyperinsulinemia and plasma glucose level independently associated with all-cause and cardiovascular mortality in Chinese people without diabetes—A post-hoc analysis of the 30-year follow-up of Da Qing diabetes and IGT study Diabetes Research and Clinical Practice ·Haixu Wang, Siyao He, Jinping Wang, Yali An, Xuan Wang, Guangwei Li, Qiuhong Gong	2022	8
14	Longitudinal Study of Childhood Adiposity and the Risk of Developing Components of Metabolic Syndrome—The Da Qing Children Cohort Study Pediatric Research ·Yanyan Chen, Yung Seng Lee, Jinping Wang, Jiang Yayun, Hui Li, Yali An, Yinghua Hu, Kok‐Onn Lee, Guangwei Li	2011	7
15	[Effect of lifestyle interventions on reduction of cardiovascular disease events and its mortality in pre-diabetic patients:long-term follow-up of Da Qing Diabetes Prevention Study]. PubMed ·Yanyan Chen, Jinping Wang, Yali An, Qiuhong Gong, Yifan He, Bo Zhang, Hui Li, Ying Shuai, Xin‐Ran Tang, Jiang Yayun, Jing Hong, Wenying Yang, Yinghua Hu, Guangwei Li	2015	6
16	Hypertriglyceridaemia predicts subsequent long‐term risk of cardiovascular events in Chinese adults: 23‐year follow‐up of the Daqing Diabetes Study Diabetes/Metabolism Research and Reviews ·Jinping Wang, Xiaoxia Shen, Siyao He, Yali An, Qiuhong Gong, Hui Li, Bo Zhang, Ying Shuai, Yanyan Chen, Yinghua Hu, Guangwei Li	2019	6
17	Circulating palmitoyl sphingomyelin levels predict the 10-year increased risk of cardiovascular disease death in Chinese adults: findings from the Da Qing Diabetes Study Cardiovascular Diabetology ·Xin Qian, Hong‐Mei Jia, Jinping Wang, Siyao He, Meng Yu, Xinxing Feng, Qiuhong Gong, Yali An, Xuan Wang, Shi Na, Hui Li, Zhong‐Mei Zou, Guangwei Li, Yanyan Chen	2024	5
18	Efficacy of 1‐hour postload plasma glucose as a suitable measurement in predicting type 2 diabetes and diabetes‐related complications: A post hoc analysis of the 30‐year follow‐up of the Da Qing IGT and Diabetes Study Diabetes Obesity and Metabolism ·Minying Peng, Siyao He, Jinping Wang, Yali An, Xin Qian, Bo Zhang, Lihong Zhang, Bo Chen, Zhiwei Yang, Guangwei Li, Qiuhong Gong, (unknown)	2024	5
19	Does high‐normal blood pressure lead to excess cardiovascular disease events and deaths in Chinese people? A post‐hoc analysis of the 30‐year follow‐up of the Da Qing IGT and Diabetes Study Diabetes Obesity and Metabolism ·Haixu Wang, Siyao He, Jinping Wang, Yali An, Xuan Wang, Guangwei Li, Ningling Sun, Qiuhong Gong, (unknown)	2023	4
20	[Subjects with impaired glucose tolerance returned to normal glucose status for six years had lower long-term risk of diabetes: 20 years follow up of Daqing diabetes prevention study]. PubMed ·Xiaoxia Shen, Jinping Wang, Yanyan Chen, Yali An, Qiuhong Gong, Bo Zhang, Jing Hong, Ying Shuai, Fang Zhao, Hui Li, Guangwei Li	2019	4

About Yali An

Yali An is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Cardiology and Cardiovascular Medicine, Epidemiology and Public Health, Environmental and Occupational Health, having authored 33 papers that have together received 1.9k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (20 papers), Metabolism, Diabetes, and Cancer (18 papers), Diabetes Treatment and Management (10 papers), Cardiovascular Health and Risk Factors (5 papers), Diabetes Management and Education (4 papers), Diabetes Management and Research (3 papers), Nutritional Studies and Diet (3 papers) and Diet, Metabolism, and Disease (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.2k citations), Pharmacy (176 citations), Physiology (469 citations), Public Health, Environmental and Occupational Health (346 citations) and Cardiology and Cardiovascular Medicine (229 citations). Yali An has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Qiuhong Gong, Jinping Wang, Guangwei Li, Yinghua Hu, Ying Shuai, Peter H. Bennett, Edward W. Gregg, Wenying Yang, Ping Zhang and Gojka Roglić. Their work appears in journals such as Diabetes Care, Diabetes Research and Clinical Practice, Diabetes Obesity and Metabolism, Diabetes and Journal of Diabetes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Yali An

Impact in

Papers in i

In The Last Decade

Yali An

Hit Papers

Peers

Countries citing papers authored by Yali An

Fields of papers citing papers by Yali An

All Works

About Yali An

Explore authors with similar magnitude of impact

Papers in